ArticleTherapeutic advances in drug safety2022

Motivating deprescribing conversations for patients with Alzheimer's disease and related dementias: a descriptive study.

Mary T Antonelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.